VANCOUVER, British Columbia, June 1, 2012 /PRNewswire/ -- Positive results from clinical trials exploring algal DHA supplementation during pregnancy and infancy were presented this week at

OR AKIVA, Israel and PRINCETON, New Jersey, May 14, 2012 /PRNewswire/ -- Regentis Biomaterials Ltd., a privately held company focused on developing proprietary hydrogels

As reported in a separate press release issued today, the Company has entered into a definitive agreement with Royal DSM ("DSM") (NYSE Euronext: DSM KON), pursuant to which the Company would be acquired through a cash tender offer, followed by a merger with a subsidiary of DSM, for a price of $38.50 per share in cash, subject to the terms and conditions of the agreement.

EXTON, Pa., May 3, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY), today announced that it has entered into a definitive agreement with Royal DSM (DSM) (NYSE Euronext: DSM

PARSIPPANY, N.J., April 3, 2012 /PRNewswire/ -- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V.